Literatures

Primary Site >> Liver Cancer

Gene >> EZH2

1.
Journal:	Br J Cancer. 2005 May 9;92(9):1754-8.
Title:	Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.
Author:	Sudo, T\|Utsunomiya, T\|Mimori, K\|Nagahara, H\|Ogawa, K\|Inoue, H\|Wakiyama, S\|Fujita, H\|Shirouzu, K\|Mori, M
PMID:	15856046

2.
Journal:	Br J Cancer. 2006 Nov 6;95(9):1202-11.
Title:	The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens.
Author:	Steele, J C\|Torr, E E\|Noakes, K L\|Kalk, E\|Moss, P A\|Reynolds, G M\|Hubscher, S G\|van Lohuizen, M\|Adams, D H\|Young, L S
PMID:	17024127

3.
Journal:	Hepatol Res. 2007 Nov;37(11):974-83.
Title:	Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.
Author:	Kondo, Yutaka\|Shen, Lanlan\|Suzuki, Seiji\|Kurokawa, Tsuyoshi\|Masuko, Kazuo\|Tanaka, Yasuhito\|Kato, Hideaki\|Mizuno, Yoshiki\|Yokoe, Masamichi\|Sugauchi, Fuminaka\|Hirashima, Noboru\|Orito, Etsuro\|Osada, Hirotaka\|Ueda, Ryuzo\|Guo, Yi\|Chen, Xinli\|Issa, Jean-Pierre
PMID:	17584191

4.
Journal:	Hepatology. 2007 Jul;46(1):200-8.
Title:	Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.
Author:	Chen, Yangchao\|Lin, Marie C\|Yao, Hong\|Wang, Hua\|Zhang, Ai-Qun\|Yu, Jun\|Hui, Chee-kin\|Lau, George K\|He, Ming-liang\|Sung, Joseph\|Kung, Hsiang-fu
PMID:	17596871

5.
Journal:	Proteomics. 2007 Sep;7(17):3097-104.
Title:	Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma.
Author:	Chen, Yangchao\|Lin, Marie Chia-mi\|Wang, Hua\|Chan, Chu-yan\|Jiang, Lei\|Ngai, Sai Ming\|Yu, Jun\|He, Ming-liang\|Shaw, Pang-Chui\|Yew, David T\|Sung, Joseph J\|Kung, Hsiang-fu
PMID:	17676662

6.
Journal:	Lab Invest. 2008 Aug;88(8):873-82.
Title:	The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
Author:	Sasaki, Motoko\|Ikeda, Hiroko\|Itatsu, Keita\|Yamaguchi, Junpei\|Sawada, Seiko\|Minato, Hiroshi\|Ohta, Tetsuo\|Nakanuma, Yasuni
PMID:	18591938

7.
Journal:	Hum Pathol. 2009 Sep;40(9):1304-11.
Title:	Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.
Author:	Yonemitsu, Yutaka\|Imazeki, Fumio\|Chiba, Tetsuhiro\|Fukai, Kenichi\|Nagai, Yuichiro\|Miyagi, Satoru\|Arai, Makoto\|Aoki, Ryutaro\|Miyazaki, Masaru\|Nakatani, Yukio\|Iwama, Atsushi\|Yokosuka, Osamu
PMID:	19386347

8.
Journal:	J Biomed Sci. 2010 May 6;17:35.
Title:	PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
Author:	Chiang, Chao-Wei\|Huang, Yi\|Leong, Ka-Wai\|Chen, Lih-Chyang\|Chen, Hua-Chien\|Chen, Shu-Jen\|Chou, Chen-Kung
PMID:	20444294

9.
Journal:	Cancer Lett. 2010 Nov 1;297(1):109-16.
Title:	RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo.
Author:	Chen, Yangchao\|Xie, Dan\|Yin Li, Wing\|Man Cheung, Chi\|Yao, Hong\|Chan, Ching Yu\|Chan, Chu-yan\|Xu, Fang-Ping\|Liu, Yan-Hui\|Sung, Joseph J Y\|Kung, Hsiang-fu
PMID:	20684863

10.
Journal:	Carcinogenesis. 2011 Jan;32(1):2-9.
Title:	Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
Author:	Zhang, Bo\|Liu, Xiao-Xiao\|He, Jian-Rong\|Zhou, Ci-Xiang\|Guo, Meng\|He, Ming\|Li, Mei-Fang\|Chen, Guo-Qiang\|Zhao, Qian
PMID:	20952513

11.
Journal:	Gut. 2011 Jul;60(7):967-76.
Title:	EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Author:	Cai, Mu-Yan\|Tong, Zhu-Ting\|Zheng, Fang\|Liao, Yi-Ji\|Wang, Yi\|Rao, Hui-Lan\|Chen, Yang-Chao\|Wu, Qiu-Liang\|Liu, Yan-Hui\|Guan, Xin-Yuan\|Lin, Marie C\|Zeng, Yi-Xin\|Kung, Hsiang-Fu\|Xie, Dan
PMID:	21330577

12.
Journal:	Oncogene. 2011 Jun 9;30(23):2670-8.
Title:	p53-paralog DNp73 oncogene is repressed by IFNalpha/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
Author:	Testoni, B\|Schinzari, V\|Guerrieri, F\|Gerbal-Chaloin, S\|Blandino, G\|Levrero, M
PMID:	21399658

13.
Journal:	Chin J Cancer. 2011 Apr;30(4):273-9.
Title:	Hepatitis B virus X protein regulates the mEZH2 promoter via the E2F1-binding site in AML12 cells.
Author:	Shi, Xiao-Yan\|Zhang, Ying-Ying\|Zhou, Xiao-Wei\|Lu, Jian-Sheng\|Guo, Ze-Kun\|Huang, Pei-Tang
PMID:	21439249

14.
Journal:	Cancer Res. 2011 Jun 1;71(11):4028-39.
Title:	EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis.
Author:	Cheng, Alfred S L\|Lau, Suki S\|Chen, Yangchao\|Kondo, Yutaka\|Li, May S\|Feng, Hai\|Ching, Arthur K\|Cheung, Kin F\|Wong, Hoi K\|Tong, Joanna H\|Jin, Hongchuan\|Choy, Kwong W\|Yu, Jun\|To, Ka F\|Wong, Nathalie\|Huang, Tim H-M\|Sung, Joseph J Y
PMID:	21512140

15.
Journal:	Hepatology. 2011 Nov;54(5):1679-89.
Title:	Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.
Author:	Yang, Fu\|Zhang, Ling\|Huo, Xi-song\|Yuan, Ji-hang\|Xu, Dan\|Yuan, Sheng-xian\|Zhu, Nan\|Zhou, Wei-ping\|Yang, Guang-shun\|Wang, Yu-zhao\|Shang, Jing-li\|Gao, Chun-fang\|Zhang, Feng-rui\|Wang, Fang\|Sun, Shu-han
PMID:	21769904

16.
Journal:	Gut. 2012 Feb;61(2):278-89.
Title:	The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
Author:	Zheng, Fang\|Liao, Yi-Ji\|Cai, Mu-Yan\|Liu, Yan-Hui\|Liu, Tian-Hao\|Chen, Shu-Peng\|Bian, Xiu-Wu\|Guan, Xin-Yuan\|Lin, Marie C\|Zeng, Yi-Xin\|Kung, Hsiang-Fu\|Xie, Dan
PMID:	21672940

17.
Journal:	Int J Cancer. 2012 Jun 1;130(11):2557-67.
Title:	3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells.
Author:	Chiba, Tetsuhiro\|Suzuki, Eiichiro\|Negishi, Masamitsu\|Saraya, Atsunori\|Miyagi, Satoru\|Konuma, Takaaki\|Tanaka, Satomi\|Tada, Motohisa\|Kanai, Fumihiko\|Imazeki, Fumio\|Iwama, Atsushi\|Yokosuka, Osamu
PMID:	21717453

18.
Journal:	Hepatology. 2012 Aug;56(2):622-31.
Title:	Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Author:	Au, Sandy Leung-Kuen\|Wong, Carmen Chak-Lui\|Lee, Joyce Man-Fong\|Fan, Dorothy Ngo-Yin\|Tsang, Felice Hoching\|Ng, Irene Oi-Lin\|Wong, Chun-Ming
PMID:	22370893

19.
Journal:	Exp Mol Pathol. 2012 Jun;92(3):318-26.
Title:	Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells.
Author:	French, B A\|Oliva, J\|Bardag-Gorce, F\|Li, J\|Zhong, J\|Buslon, V\|French, S W
PMID:	22465358

20.
Journal:	Diagn Pathol. 2012 Jul 18;7:86.
Title:	Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.
Author:	Hajosi-Kalcakosz, Szofia\|Dezso, Katalin\|Bugyik, Edina\|Bodor, Csaba\|Paku, Sandor\|Pavai, Zoltan\|Halasz, Judit\|Schlachter, Krisztina\|Schaff, Zsuzsa\|Nagy, Peter
PMID:	22809481

21.
Journal:	PLoS One. 2012;7(9):e44206.
Title:	MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
Author:	Xia, Hongping\|Ooi, London Lucien P J\|Hui, Kam M
PMID:	22962603

22.
Journal:	OMICS. 2012 Nov;16(11):579-88.
Title:	Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma.
Author:	Poma, Paola\|Labbozzetta, Manuela\|Vivona, Nicoletta\|Porcasi, Rossana\|D'Alessandro, Natale\|Notarbartolo, Monica
PMID:	23095110

23.
Journal:	Oncogene. 2013 Mar 28;32(13):1616-25.
Title:	HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer.
Author:	Kim, K\|Jutooru, I\|Chadalapaka, G\|Johnson, G\|Frank, J\|Burghardt, R\|Kim, S\|Safe, S
PMID:	22614017

24.
Journal:	Oncol Rep. 2013 Mar;29(3):1037-42.
Title:	RNAi-mediated EZH2 depletion decreases MDR1 expression and sensitizes multidrug-resistant hepatocellular carcinoma cells to chemotherapy.
Author:	Tang, Bo\|Zhang, Yi\|Liang, Rui\|Gao, Zhenming\|Sun, Deguang\|Wang, Liming
PMID:	23291714

25.
Journal:	N Biotechnol. 2013 May 25;30(4):381-4.
Title:	Genetics and epigenetics of liver cancer.
Author:	Ozen, Cigdem\|Yildiz, Gokhan\|Dagcan, Alper Tunga\|Cevik, Dilek\|Ors, Aysegul\|Keles, Umur\|Topel, Hande\|Ozturk, Mehmet
PMID:	23392071

26.
Journal:	Cancer Sci. 2013 Jun;104(6):750-9.
Title:	Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2.
Author:	Wang, Shanshan\|Zhu, Yu\|He, Hongyong\|Liu, Jing\|Xu, Le\|Zhang, Heng\|Liu, Haiou\|Liu, Weisi\|Liu, Yidong\|Pan, Deng\|Chen, Lin\|Wu, Qian\|Xu, Jiejie\|Gu, Jianxin
PMID:	23421437

27.
Journal:	Pathol Res Pract. 2013 Apr;209(4):249-54.
Title:	Primary liver sarcomatous carcinoma: report of two cases and review of the literature.
Author:	Giunchi, Francesca\|Vasuri, Francesco\|Baldin, Pamela\|Rosini, Francesca\|Corti, Barbara\|D'Errico-Grigioni, Antonia
PMID:	23484778

28.
Journal:	Eur J Surg Oncol. 2013 Jun;39(6):655-61.
Title:	Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
Author:	Tamagawa, H\|Oshima, T\|Numata, M\|Yamamoto, N\|Shiozawa, M\|Morinaga, S\|Nakamura, Y\|Yoshihara, M\|Sakuma, Y\|Kameda, Y\|Akaike, M\|Yukawa, N\|Rino, Y\|Masuda, M\|Miyagi, Y
PMID:	23523318

29.
Journal:	Life Sci. 2013 May 20;92(17-19):896-902.
Title:	Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu.
Author:	Zhang, Yi\|Liu, Guangpu\|Lin, Changwei\|Liao, Guoqing\|Tang, Bo
PMID:	23562851

30.
Journal:	Front Med. 2013 Jun;7(2):231-41.
Title:	Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins.
Author:	Au, Sandy Leung-Kuen\|Ng, Irene Oi-Lin\|Wong, Chun-Ming
PMID:	23620257

31.
Journal:	Mol Cancer Ther. 2013 Aug;12(8):1651-64.
Title:	Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model.
Author:	Sia, Kian Chuan\|Huynh, Hung\|Chung, Alexander Yaw Fui\|Ooi, London Lucien Peng Jin\|Lim, Kiat Hon\|Hui, Kam Man\|Lam, Paula Yeng Po
PMID:	23720769

32.
Journal:	PLoS One. 2013 Jun 27;8(6):e68226.
Title:	EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Author:	Au, Sandy Leung-Kuen\|Wong, Carmen Chak-Lui\|Lee, Joyce Man-Fong\|Wong, Chun-Ming\|Ng, Irene Oi-Lin
PMID:	23826380

33.
Journal:	PLoS One. 2013 Sep 10;8(9):e74870.
Title:	Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.
Author:	Yu, Yung-Luen\|Su, Kuo-Jung\|Hsieh, Yi-Hsien\|Lee, Hsiang-Lin\|Chen, Tzy-Yen\|Hsiao, Pei-Ching\|Yang, Shun-Fa
PMID:	24040354

34.
Journal:	BMC Med Genomics. 2013 Sep 30;6:35.
Title:	Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers.
Author:	Cohen, Adam L\|Piccolo, Stephen R\|Cheng, Luis\|Soldi, Rafaella\|Han, Bing\|Johnson, W Evan\|Bild, Andrea H
PMID:	24079712

35.
Journal:	Hepatobiliary Surg Nutr. 2013 Apr;2(2):78-83.
Title:	Effects of EZH2 gene on the growth and migration of hepatocellular carcinoma HepG2 cells.
Author:	Zhao, Hongtao\|Xu, Yiyao\|Mao, Yilei\|Zhang, Yangde
PMID:	24570920

36.
Journal:	Tumour Biol. 2014 Jan;35(1):205-12.
Title:	A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2.
Author:	Wang, Yan\|Ma, Jingyi\|Chow, Sheung Ching\|Li, Chi Han\|Xiao, Zhangang\|Feng, Ru\|Fu, Jie\|Chen, Yangchao
PMID:	23897557

37.
Journal:	Hepatology. 2014 May;59(5):1850-63.
Title:	c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma.
Author:	Wang, Lei\|Zhang, Xiang\|Jia, Lin-Tao\|Hu, Si-Jun\|Zhao, Jing\|Yang, Jian-Dong\|Wen, Wei-Hong\|Wang, Zhe\|Wang, Tao\|Zhao, Jun\|Wang, Rui-An\|Meng, Yan-Ling\|Nie, Yong-Zhan\|Dou, Ke-Feng\|Chen, Si-Yi\|Yao, Li-Bo\|Fan, Dai-Ming\|Zhang, Rui\|Yang, An-Gang
PMID:	24002871

38.
Journal:	Carcinogenesis. 2014 Jan;35(1):53-61.
Title:	Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B.
Author:	Tian, Yi\|Ni, Dongjing\|Yang, Weibing\|Zhang, Yi\|Zhao, Keji\|Song, Jianxun\|Mao, Qing\|Tian, Zhiqiang\|van Velkinburgh, Jennifer C\|Yang, Di\|Wu, Yuzhang\|Ni, Bing
PMID:	24067902

39.
Journal:	J Hepatol. 2014 Mar;60(3):590-8.
Title:	MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Author:	Xu, Leibo\|Beckebaum, Susanne\|Iacob, Speranta\|Wu, Gang\|Kaiser, Gernot M\|Radtke, Arnold\|Liu, Chao\|Kabar, Iyad\|Schmidt, Hartmut H\|Zhang, Xiaoyong\|Lu, Mengji\|Cicinnati, Vito R
PMID:	24211739

40.
Journal:	J Hepatol. 2014 Oct;61(4):832-9.
Title:	The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma.
Author:	Gao, Shu-Bin\|Xu, Bin\|Ding, Li-Hong\|Zheng, Qi-Lin\|Zhang, Li\|Zheng, Qi-Fan\|Li, Shan-Hua\|Feng, Zi-Jie\|Wei, Jie\|Yin, Zhen-Yu\|Hua, Xianxin\|Jin, Guang-Hui
PMID:	24845612

41.
Journal:	Oncogenesis. 2014 May 26;3:e104.
Title:	Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells.
Author:	Hibino, S\|Saito, Y\|Muramatsu, T\|Otani, A\|Kasai, Y\|Kimura, M\|Saito, H
PMID:	24861464

42.
Journal:	Mol Cancer Res. 2014 Oct;12(10):1388-97.
Title:	EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma.
Author:	Gao, Shu-Bin\|Zheng, Qi-Fan\|Xu, Bin\|Pan, Chang-Bao\|Li, Kang-Li\|Zhao, Yue\|Zheng, Qi-Lin\|Lin, Xiao\|Xue, Li-Xiang\|Jin, Guang-Hui
PMID:	24916103

43.
Journal:	Int J Clin Exp Pathol. 2014 Apr 15;7(5):2496-507. eCollection 2014.
Title:	Histone-modifying genes as biomarkers in hepatocellular carcinoma.
Author:	Hung, Shih-Ya\|Lin, Hui-Hua\|Yeh, Kun-Tu\|Chang, Jan-Gowth
PMID:	24966962

44.
Journal:	PLoS One. 2014 Sep 16;9(9):e107251.
Title:	Aberrant upregulation of 14-3-3sigma and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma.
Author:	Zhang, Yi\|Li, Yang\|Lin, Changwei\|Ding, Jie\|Liao, Guoqing\|Tang, Bo
PMID:	25226601

45.
Journal:	Int J Clin Exp Med. 2014 Nov 15;7(11):4038-50. eCollection 2014.
Title:	Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses.
Author:	Zhou, Xu\|Zhu, Hua-Qiang\|Lu, Jun
PMID:	25550913

46.
Journal:	Genet Test Mol Biomarkers. 2015 Jan;19(1):30-6.
Title:	miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.
Author:	Wang, Gang\|Sun, Yubei\|He, Yifu\|Ji, Chushu\|Hu, Bing\|Sun, Yuping
PMID:	25494962

47.
Journal:	J Hepatol. 2015 May;62(5):1100-11.
Title:	A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients.
Author:	Feng, Hai\|Yu, Zhuo\|Tian, Yuan\|Lee, Ying-Ying\|Li, May S\|Go, Minnie Y Y\|Cheung, Yue-Sun\|Lai, Paul B S\|Chan, Andrew M L\|To, Ka-Fai\|Chan, Henry L Y\|Sung, Joseph J Y\|Cheng, Alfred S L
PMID:	25500144

48.
Journal:	J Invest Dermatol. 2015 Apr;135(4):960-969.
Title:	miR-214 as a key hub that controls cancer networks: small player, multiple functions.
Author:	Penna, Elisa\|Orso, Francesca\|Taverna, Daniela
PMID:	25501033

49.
Journal:	Cancer Lett. 2015 Apr 10;359(2):198-205.
Title:	DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Author:	Ning, Xianghong\|Shi, Zhendong\|Liu, Xi\|Zhang, Anling\|Han, Lei\|Jiang, Kui\|Kang, Chunsheng\|Zhang, Qingyu
PMID:	25595591

50.
Journal:	J Pathol. 2015 May;236(1):1-4.
Title:	CUL4B: a novel epigenetic driver in Wnt/beta-catenin-dependent hepatocarcinogenesis.
Author:	Mok, Myth T S\|Cheng, Alfred S L
PMID:	25664533

51.
Journal:	PLoS Genet. 2015 Feb 18;11(2):e1004873.
Title:	Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets.
Author:	Zheng, Fang\|Liao, Yi-Ji\|Cai, Mu-Yan\|Liu, Tian-Hao\|Chen, Shu-Peng\|Wu, Pei-Hong\|Wu, Long\|Bian, Xiu-Wu\|Guan, Xin-Yuan\|Zeng, Yi-Xin\|Yuan, Yun-Fei\|Kung, Hsiang-Fu\|Xie, Dan
PMID:	25693145

52.
Journal:	J Hepatol. 2015 Oct;63(4):886-95.
Title:	Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling.
Author:	Fu, Wei-Ming\|Zhu, Xiao\|Wang, Wei-Mao\|Lu, Ying-Fei\|Hu, Bao-Guang\|Wang, Hua\|Liang, Wei-Cheng\|Wang, Shan-Shan\|Ko, Chun-Hay\|Waye, Mary Miu-Yee\|Kung, Hsiang-Fu\|Li, Gang\|Zhang, Jin-Fang
PMID:	26024833

53.
Journal:	Int J Clin Exp Pathol. 2015 May 1;8(5):4972-80. eCollection 2015.
Title:	MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
Author:	Liu, Fenghua\|He, Yukai\|Shu, Ronghua\|Wang, Sikui
PMID:	26191190

54.
Journal:	Med Oncol. 2015 Sep;32(9):226.
Title:	Long noncoding RNA-LET, which is repressed by EZH2, inhibits cell proliferation and induces apoptosis of nasopharyngeal carcinoma cell.
Author:	Sun, Qiuzhen\|Liu, Hongbing\|Li, Lihua\|Zhang, Shaorong\|Liu, Ke\|Liu, Yuehui\|Yang, Chunping
PMID:	26243049

55.
Journal:	Cancer Res. 2015 Nov 15;75(22):4803-16.
Title:	Histone Deacetylase HDAC8 Promotes Insulin Resistance and beta-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.
Author:	Tian, Yuan\|Wong, Vincent W S\|Wong, Grace L H\|Yang, Weiqin\|Sun, Hanyong\|Shen, Jiayun\|Tong, Joanna H M\|Go, Minnie Y Y\|Cheung, Yue S\|Lai, Paul B S\|Zhou, Mingyan\|Xu, Gang\|Huang, Tim H M\|Yu, Jun\|To, Ka F\|Cheng, Alfred S L\|Chan, Henry L Y
PMID:	26383163

56.
Journal:	Nat Commun. 2015 Sep 25;6:8494.
Title:	EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
Author:	Liu, Haiou\|Liu, Yidong\|Liu, Weisi\|Zhang, Weijuan\|Xu, Jiejie
PMID:	26404566

57.
Journal:	Oncotarget. 2015 Nov 24;6(37):39865-76.
Title:	Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.
Author:	Jiang, Yunyun\|Malouf, Gabriel G\|Zhang, Jianping\|Zheng, Xiaofeng\|Chen, Yunxin\|Thompson, Erika J\|Weinstein, John N\|Yuan, Ying\|Spano, Jean-Philippe\|Broaddus, Russell\|Tannir, Nizar M\|Khayat, David\|Lu, Karen H\|Su, Xiaoping
PMID:	26431491

58.
Journal:	J Biol Chem. 2015 Nov 20;290(47):28489-501.
Title:	Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma.
Author:	Liu, Weisi\|Liu, Yidong\|Liu, Haiou\|Zhang, Weijuan\|Fu, Qiang\|Xu, Jiejie\|Gu, Jianxin
PMID:	26442588

59.
Journal:	Oncotarget. 2015 Dec 1;6(38):40940-52.
Title:	Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.
Author:	Xie, Cheng-Rong\|Li, Zhao\|Sun, Hong-Guang\|Wang, Fu-Qiang\|Sun, Yu\|Zhao, Wen-Xiu\|Zhang, Sheng\|Zhao, Wen-Xing\|Wang, Xiao-Min\|Yin, Zhen-Yu
PMID:	26517514

60.
Journal:	Am J Cancer Res. 2015 Sep 15;5(10):2969-79. eCollection 2015.
Title:	Genetic alteration and misexpression of Polycomb group genes in hepatocellular carcinoma.
Author:	Gao, Shu-Bin\|Sun, Shi-Long\|Zheng, Qi-Lin\|Zhang, Li\|Zhu, Yuequan\|Jin, Guang-Hui\|Xue, Li-Xiang
PMID:	26693053

61.
Journal:	Oncogene. 2016 Feb 11;35(6):715-26.
Title:	Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
Author:	Fan, H\|Zhang, H\|Pascuzzi, P E\|Andrisani, O
PMID:	25893293

62.
Journal:	J Hepatol. 2016 Jan;64(1):87-93.
Title:	Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications.
Author:	Sciarra, Amedeo\|Di Tommaso, Luca\|Nakano, Masayuki\|Destro, Annarita\|Torzilli, Guido\|Donadon, Matteo\|Maggioni, Marco\|Bosari, Silvano\|Bulfamante, Gaetano\|Matsuda, Masanori\|Fujii, Hideki\|Ichikawa, Tomoaki\|Morisaka, Hiroyuki\|Sano, Katsuhiro\|Ichikawa, Shintaro\|
PMID:	26343958

63.
Journal:	Oncol Rep. 2016 Feb;35(2):1083-90.
Title:	Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma.
Author:	Huang, Da\|Wang, Xiaobei\|Zhuang, Chunbo\|Shi, Wuhe\|Liu, Mu\|Tu, Qiming\|Zhang, Detai\|Hu, Lihua
PMID:	26718325

64.
Journal:	J Hematol Oncol. 2016 Jan 6;9:1.
Title:	MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
Author:	Ma, De-Ning\|Chai, Zong-Tao\|Zhu, Xiao-Dong\|Zhang, Ning\|Zhan, Di-Hua\|Ye, Bo-Gen\|Wang, Cheng-Hao\|Qin, Cheng-Dong\|Zhao, Yi-Ming\|Zhu, Wei-Ping\|Cao, Man-Qing\|Gao, Dong-Mei\|Sun, Hui-Chuan\|Tang, Zhao-You
PMID:	26733151

65.
Journal:	J Pathol. 2016 Apr;238(5):651-64.
Title:	Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-kappaB in hepatocellular carcinoma.
Author:	Tsang, Daisy P F\|Wu, William K K\|Kang, Wei\|Lee, Ying-Ying\|Wu, Feng\|Yu, Zhuo\|Xiong, Lei\|Chan, Anthony W\|Tong, Joanna H\|Yang, Weiqin\|Li, May S M\|Lau, Suki S\|Li, Xiangchun\|Lee, Sau-Dan\|Yang, Yihua\|Lai, Paul B S\|Yu, Dae-Yeul\|Xu, Gang\|Lo, Kwok-Wai\|Chan, Matthe
PMID:	26800240

66.
Journal:	Mol Med Rep. 2016 Mar;13(3):2724-8.
Title:	Enhancer of zeste homolog 2 depletion arrests the proliferation of hepatoblastoma cells.
Author:	Wang, Yue\|Xiao, Yongtao\|Chen, Kai\|Chen, Sheng\|Zhang, Min\|Wu, Zhixiang\|Wu, Yeming
PMID:	26848027

67.
Journal:	Oncoscience. 2016 Jan 29;3(1):9-20.
Title:	In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes.
Author:	Liu, Tsang-Pai\|Hong, Yi-Han\|Tung, Kwang-Yi\|Yang, Pei-Ming
PMID:	26973856

68.
Journal:	J Mol Cell Biol. 2016 Mar 21. pii: mjw010.
Title:	microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect.
Author:	Han, Han\|Li, Wenjuan\|Shen, Hongxing\|Zhang, Jinxiang\|Zhu, Yahui\|Li, Youjun
PMID:	27001970

69.
Journal:	Carcinogenesis. 2016 Jun;37(6):557-566.
Title:	CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.
Author:	Li, Chang-Peng\|Cai, Mu-Yan\|Jiang, Li-Juan\|Mai, Shi-Juan\|Chen, Jie-Wei\|Wang, Feng-Wei\|Liao, Yi-Ji\|Chen, Wen-Hui\|Jin, Xiao-Han\|Pei, Xiao-Qing\|Guan, Xin-Yuan\|Zeng, Mu-Sheng\|Xie, Dan
PMID:	27207647

70.
Journal:	Sci Rep. 2016 May 27;6:26971.
Title:	The NKD1/Rac1 feedback loop regulates the invasion and migration ability of hepatocarcinoma cells.
Author:	Li, Jie\|Zhang, Sheng\|Hu, Qing\|Zhang, Kang\|Jin, Jianbin\|Zheng, Xuqing\|Yin, Zhenyu\|Wang, Xiaomin
PMID:	27231134

71.
Journal:	Nat Struct Mol Biol. 2016 Jul;23(7):631-9.
Title:	lnc-beta-Catm elicits EZH2-dependent beta-catenin stabilization and sustains liver CSC self-renewal.
Author:	Zhu, Pingping\|Wang, Yanying\|Huang, Guanling\|Ye, Buqing\|Liu, Benyu\|Wu, Jiayi\|Du, Ying\|He, Lei\|Fan, Zusen
PMID:	27239797

72.
Journal:	Oncotarget. 2016 Aug 2;7(31):50131-50149.
Title:	Inflammatory related gene IKKalpha, IKKbeta, IKKgamma cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.
Author:	An, Jiahui\|Wu, Mengying\|Xin, Xiaoru\|Lin, Zhuojia\|Li, Xiaonan\|Zheng, Qidi\|Gui, Xin\|Li, Tianming\|Pu, Hu\|Li, Haiyan\|Lu, Dongdong
PMID:	27367027

73.
Journal:	J Mol Med (Berl). 2016 Nov;94(11):1281-1296.
Title:	Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Author:	Sui, Cheng-Jun\|Zhou, Yan-Ming\|Shen, Wei-Feng\|Dai, Bing-Hua\|Lu, Jiong-Jiong\|Zhang, Min-Feng\|Yang, Jia-Mei
PMID:	27380494

74.
Journal:	Gene. 2016 Oct 30;592(1):172-178.
Title:	Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression.
Author:	Yang, Xiao-Jun\|Huang, Chao-Qun\|Peng, Chun-Wei\|Hou, Jin-Xuan\|Liu, Jiu-Yang
PMID:	27496341

75.
Journal:	Biochem Biophys Res Commun. 2016 Sep 16;478(2):811-7.
Title:	Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Author:	Fang, Jing\|Sun, Cheng-Cao\|Gong, Cheng
PMID:	27501756

76.
Journal:	Tumour Biol. 2016 Nov;37(11):14903-14914.
Title:	Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma.
Author:	Huang, Yun\|Tao, Yiming\|Hu, Kuan\|Lin, Feng\|Li, Xinying\|Feng, Tiecheng\|Wang, Zhi-Ming
PMID:	27644248

77.
Journal:	Onco Targets Ther. 2016 Nov 24;9:6987-6998.
Title:	The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis.
Author:	Zhai, Run\|Tang, Fang\|Gong, Jianhua\|Zhang, Jing\|Lei, Biao\|Li, Bo\|Wei, Yangchao\|Liang, Xingsi\|Tang, Bo\|He, Songqing
PMID:	27920552

78.
Journal:	Oncotarget. 2017 Jun 13;8(24):38227-38238.
Title:	Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.
Author:	Nie, Fengqi\|Yu, Xiang\|Huang, Mingde\|Wang, Yunfei\|Xie, Min\|Ma, Hongwei\|Wang, Zhaoxia\|De, Wei\|Sun, Ming
PMID:	27246976

79.
Journal:	Oncogene. 2017 Apr 6;36(14):2030-2044.
Title:	A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.
Author:	Wijetunga, N A\|Pascual, M\|Tozour, J\|Delahaye, F\|Alani, M\|Adeyeye, M\|Wolkoff, A W\|Verma, A\|Greally, J M
PMID:	27721404

80.
Journal:	Biomed Pharmacother. 2017 Jan;85:472-478.
Title:	miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/beta-catenin signaling pathway.
Author:	Zhang, Jun-Jie\|Chen, Jiang-Tao\|Hua, Long\|Yao, Kun-Hou\|Wang, Chen-Yu
PMID:	27890434

81.
Journal:	Biomed Pharmacother. 2017 Jan;85:348-354.
Title:	Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Author:	Zhou, Meng\|Zhang, Xiao-Yu\|Yu, Xi
PMID:	27899259

82.
Journal:	Biomed Pharmacother. 2017 May;89:857-863.
Title:	Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Author:	Liu, Jinxia\|Lu, Cuihua\|Xiao, Mingbing\|Jiang, Feng\|Qu, Lishuai\|Ni, Runzhou
PMID:	28282787

83.
Journal:	Biomed Pharmacother. 2017 May;89:926-932.
Title:	Long non-coding RNA HNF1A-AS1 promotes hepatocellular carcinoma cell proliferation by repressing NKD1 and P21 expression.
Author:	Wang, Cong\|Mou, Lin\|Chai, Hai-Xia\|Wang, Feng\|Yin, Yun-Zhi\|Zhang, Xiao-Yu
PMID:	28292020

84.
Journal:	Cell Death Differ. 2017 May;24(5):889-902.
Title:	Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Author:	Gnani, Daniela\|Romito, Ilaria\|Artuso, Simona\|Chierici, Marco\|De Stefanis, Cristiano\|Panera, Nadia\|Crudele, Annalisa\|Ceccarelli, Sara\|Carcarino, Elena\|D'Oria, Valentina\|Porru, Manuela\|Giorda, Ezio\|Ferrari, Karin\|Miele, Luca\|Villa, Erica\|Balsano, Clara\|Pasi
PMID:	28338656

85.
Journal:	Biomed Pharmacother. 2017 Jun;90:100-108.
Title:	Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Author:	Deng, Xin\|Zhao, Xiao Fang\|Liang, Xing Qiu\|Chen, Ran\|Pan, Yi Feng\|Liang, Jian
PMID:	28343069

86.
Journal:	Mol Oncol. 2017 Sep;11(9):1225-1240.
Title:	HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.
Author:	Chen, Shi-Lu\|Liu, Li-Li\|Lu, Shi-Xun\|Luo, Rong-Zhen\|Wang, Chun-Hua\|Wang, Hong\|Cai, Shao-Hang\|Yang, Xia\|Xie, Dan\|Zhang, Chris Zhiyi\|Yun, Jing-Ping
PMID:	28580773

87.
Journal:	Biol Open. 2017 Sep 15;6(9):1310-1316.
Title:	Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression.
Author:	Sha, Sha\|Yuan, Dongya\|Liu, Yuejun\|Han, Baosan\|Zhong, Nanbert
PMID:	28760736

88.
Journal:	Cancer Biomark. 2017 Dec 6;20(4):511-519.
Title:	Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214.
Author:	Gou, Xun\|Zhao, Xiyan\|Wang, Zhengrong
PMID:	28800314

89.
Journal:	Mol Cancer. 2017 Aug 14;16(1):136.
Title:	STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4.
Author:	Wang, Hui\|Huo, Xisong\|Yang, Xin-Rong\|He, Jia\|Cheng, Lijun\|Wang, Na\|Deng, Xuan\|Jin, Haojie\|Wang, Ning\|Wang, Cun\|Zhao, Fangyu\|Fang, Jingyuan\|Yao, Ming\|Fan, Jia\|Qin, Wenxin
PMID:	28810927

90.
Journal:	Eur Rev Med Pharmacol Sci. 2017 Aug;21(15):3402-3411.
Title:	Promotion of LncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1.
Author:	Yu, J\|Hong, J-F\|Kang, J\|Liao, L-H\|Li, C-D
PMID:	28829501

91.
Journal:	Oncogene. 2017 Dec 14;36(50):6895-6905.
Title:	Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
Author:	Feng, G X\|Li, J\|Yang, Z\|Zhang, S Q\|Liu, Y X\|Zhang, W Y\|Ye, L H\|Zhang, X D
PMID:	28846110

92.
Journal:	Eur J Pharmacol. 2017 Nov 15;815:173-180.
Title:	20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
Author:	Li, Qi\|Li, Bai\|Dong, Chengya\|Wang, Yajie\|Li, Qi
PMID:	28928088

93.
Journal:	Am J Cancer Res. 2017 Sep 1;7(9):1874-1883. eCollection 2017.
Title:	Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
Author:	Gao, Shu-Bin\|Li, Kang-Li\|Qiu, Huan\|Zhu, Ling-Yu\|Pan, Chang-Bao\|Zhao, Yue\|Wei, Shu-Hua\|Shi, Shu\|Jin, Guang-Hui\|Xue, Li-Xiang
PMID:	28979810

94.
Journal:	Cell Death Dis. 2017 Oct 5;8(10):e3092.
Title:	Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression.
Author:	Chen, Zhenyao\|Chen, Xin\|Chen, Ping\|Yu, Shanxun\|Nie, Fengqi\|Lu, Binbin\|Zhang, Te\|Zhou, Yue\|Chen, Qinnan\|Wei, Chenchen\|Wang, Wei\|Wang, Zhaoxia
PMID:	28981099

95.
Journal:	Oncotarget. 2017 Jul 26;8(41):70172-70182.
Title:	Long non-coding RNA CARLo-5 promotes tumor progression in hepatocellular carcinoma via suppressing miR-200b expression.
Author:	Dou, Chunqing\|Sun, Liyuan\|Jin, Xin\|Han, Mingming\|Zhang, Bao\|Jiang, Xian\|Lv, Jinyong\|Li, Tao
PMID:	29050269

96.
Journal:	Oncol Lett. 2017 Nov;14(5):6109-6116.
Title:	Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer.
Author:	Wang, Jun\|Huang, Fang\|Huang, Jian\|Kong, Jindan\|Liu, Shenglan\|Jin, Jun
PMID:	29113254

97.
Journal:	Oncotarget. 2017 Aug 18;8(48):84153-84167.
Title:	Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3.
Author:	Ma, Zhonghua\|Huang, Hesuyuan\|Wang, Jirong\|Zhou, Yan\|Pu, Fuxing\|Zhao, Qinghong\|Peng, Peng\|Hui, Bingqing\|Ji, Hao\|Wang, Keming
PMID:	29137412

98.
Journal:	Mol Med Rep. 2017 Dec;16(6):9494-9502.
Title:	MicroRNA137 has a suppressive role in liver cancer via targeting EZH2.
Author:	Cui, Shichang\|Sun, Yanlei\|Liu, Yang\|Liu, Chengbiao\|Wang, Jinbao\|Hao, Guang\|Sun, Qidong
PMID:	29152663

99.
Journal:	Oncotarget. 2017 Oct 10;8(61):103785-103796.
Title:	SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/beta-catenin activation.
Author:	Li, Xiaopeng\|Li, Ming\|Chen, JiaLi\|Dai, Hua\|Wang, Liang\|Xiong, Ying\|Zhong, Yuanbin\|Zhang, Lunli
PMID:	29262600

100.
Journal:	Oncotarget. 2017 Nov 27;8(65):109509-109521.
Title:	Long non-coding RNA HOXA11-AS promotes the proliferation HCC cells by epigenetically silencing DUSP5.
Author:	Liu, Bin\|Li, Jing\|Liu, Xiaoling\|Zheng, Min\|Yang, Ye\|Lyu, Qian\|Jin, Li
PMID:	29312625

101.
Journal:	Histopathology. 2018 Feb;72(3):414-422.
Title:	From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
Author:	Vasuri, Francesco\|Malvi, Deborah\|Bonora, Sonia\|Fittipaldi, Silvia\|Renzulli, Matteo\|Tovoli, Francesco\|Golfieri, Rita\|Bolondi, Luigi\|D'Errico, Antonia
PMID:	28881044

102.
Journal:	Gut. 2018 May;67(5):931-944.
Title:	Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.
Author:	Zhou, Jingying\|Liu, Man\|Sun, Hanyong\|Feng, Yu\|Xu, Liangliang\|Chan, Anthony W H\|Tong, Joanna H\|Wong, John\|Chong, Charing Ching Ning\|Lai, Paul B S\|Wang, Hector Kwong-Sang\|Tsang, Shun-Wa\|Goodwin, Tyler\|Liu, Rihe\|Huang, Leaf\|Chen, Zhiwei\|Sung, Joseph Jy\|Chow,
PMID:	28939663

103.
Journal:	Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G559-G565.
Title:	lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Author:	Huang, Xinli\|Gao, Yun\|Qin, Jianjie\|Lu, Sen
PMID:	29097358

104.
Journal:	Mol Carcinog. 2018 Mar;57(3):408-418.
Title:	LncAPC drives Wnt/beta-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition.
Author:	Fu, Xiaomin\|Lin, Jizhen\|Qin, Fujun\|Yang, Zihe\|Ding, Yuechao\|Zhang, Yong\|Han, Lu\|Zhu, Xiaoyan\|Zhang, Qinxian
PMID:	29144570

105.
Journal:	Biochem Biophys Res Commun. 2018 Jan 22;495(4):2622-2629.
Title:	Long noncoding RNA PCAT-1 acts as an oncogene in osteosarcoma by reducing p21 levels.
Author:	Huang, Jiang\|Deng, Gaorong\|Liu, Tianmi\|Chen, Wenzhao\|Zhou, Yang
PMID:	29291409

106.
Journal:	J Exp Clin Cancer Res. 2018 Jan 9;37(1):3.
Title:	EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
Author:	Chen, Shaofei\|Pu, Jiarui\|Bai, Jie\|Yin, Yuping\|Wu, Ke\|Wang, Jiliang\|Shuai, Xiaoming\|Gao, Jinbo\|Tao, Kaixiong\|Wang, Guobin\|Li, Hang
PMID:	29316949

107.
Journal:	Pharmacol Ther. 2018 Jun;186:138-151.
Title:	CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Author:	Mok, Myth T\|Zhou, Jingying\|Tang, Wenshu\|Zeng, Xuezhen\|Oliver, Antony W\|Ward, Simon E\|Cheng, Alfred S
PMID:	29360538

108.
Journal:	Oncol Lett. 2018 Mar;15(3):2953-2961.
Title:	Expression of EZH2 is associated with poor outcome in colorectal cancer.
Author:	Chen, Zhuanpeng\|Yang, Ping\|Li, Wanglin\|He, Feng\|Wei, Jianchang\|Zhang, Tong\|Zhong, Junbin\|Chen, Huacui\|Cao, Jie
PMID:	29435024

109.
Journal:	Clin Lab. 2018 Jan 1;64(1):85-91.
Title:	Association between EZH2 Genetic Variants and Hepatocellular Carcinoma in a Chinese Han Population.
Author:	Li, Siyao\|Sun, Shilong\|Yu, Shilong\|Dong, Zhuo\|Jiang, Kuo\|Xiang, Linlin\|Li, Haiying
PMID:	29479874

110.
Journal:	Molecules. 2018 Mar 2;23(3). pii: molecules23030567.
Title:	Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
Author:	Ding, Hong\|Lu, Wen Chao\|Hu, Jun Chi\|Liu, Yu-Chih\|Zhang, Chen Hua\|Lian, Fu Lin\|Zhang, Nai Xia\|Meng, Fan Wang\|Luo, Cheng\|Chen, Kai Xian
PMID:	29498708

111.
Journal:	Mol Med Rep. 2018 May;17(5):7460.
Title:	[Corrigendum] MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2.
Author:	Cui, Shichang\|Sun, Yanlei\|Liu, Yang\|Liu, Chengbiao\|Wang, Jinbao\|Hao, Guang\|Sun, Qidong
PMID:	29568886

112.
Journal:	J Cell Physiol. 2018 Sep;233(9):6508-6517.
Title:	The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma.
Author:	Sanna, Luca\|Marchesi, Irene\|Melone, Mariarosa A B\|Bagella, Luigi
PMID:	29574790

113.
Journal:	Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3509-E3518.
Title:	Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.
Author:	Bugide, Suresh\|Green, Michael R\|Wajapeyee, Narendra
PMID:	29581297

114.
Journal:	Cancer Lett. 2018 Jul 10;426:98-108.
Title:	MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.
Author:	Zhang, Xiang\|Zhang, Xiao\|Wang, Ting\|Wang, Lei\|Tan, Zhijun\|Wei, Wei\|Yan, Bo\|Zhao, Jing\|Wu, Kaichun\|Yang, Angang\|Zhang, Rui\|Jia, Lintao
PMID:	29653269

115.
Journal:	Cell Physiol Biochem. 2018;46(3):1122-1133.
Title:	Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC.
Author:	Zeng, Bing\|Lin, Zewei\|Ye, Huilin\|Cheng, Di\|Zhang, Guangtao\|Zhou, Jindu\|Huang, Zhifeng\|Wang, Meng\|Cai, Canfeng\|Zeng, Jun\|Tang, Chaoming\|Liu, Jikui
PMID:	29669339

116.
Journal:	Biomed Pharmacother. 2018 Aug;104:137-144.
Title:	LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
Author:	Wei, Congxin\|Wang, Hong\|Xu, Fei\|Liu, Zeng\|Jiang, Runde
PMID:	29772433

117.
Journal:	Mol Ther Nucleic Acids. 2018 Jun 1;11:23-33.
Title:	Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors.
Author:	Wang, Hong\|Guo, Rui\|Du, Zhonghua\|Bai, Ling\|Li, Lingyu\|Cui, Jiuwei\|Li, Wei\|Hoffman, Andrew R\|Hu, Ji-Fan
PMID:	29858058

118.
Journal:	Nucleic Acids Res. 2018 Sep 28;46(17):8832-8847.
Title:	Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.
Author:	Lee, Ying-Ying\|Mok, Myth Ts\|Kang, Wei\|Yang, Weiqin\|Tang, Wenshu\|Wu, Feng\|Xu, Liangliang\|Yan, Mingfei\|Yu, Zhuo\|Lee, Sau-Dan\|Tong, Joanna H M\|Cheung, Yue-Sun\|Lai, Paul B S\|Yu, Dae-Yeul\|Wang, Qianben\|Wong, Grace L H\|Chan, Andrew M\|Yip, Kevin Y\|To, Ka-Fai\|Che
PMID:	29992318

119.
Journal:	Cancer Cell Int. 2018 Jul 11;18:98.
Title:	Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2.
Author:	Guo, Jianping\|Hao, Chong\|Wang, Congcong\|Li, Luo
PMID:	30008615

120.
Journal:	Front Physiol. 2018 Jul 27;9:1019.
Title:	Dysfunction of Sister Chromatids Separation Promotes Progression of Hepatocellular Carcinoma According to Analysis of Gene Expression Profiling.
Author:	Sun, Baozhen\|Lin, Guibo\|Ji, Degang\|Li, Shuo\|Chi, Guonan\|Jin, Xingyi
PMID:	30100882

121.
Journal:	EBioMedicine. 2018 Sep;35:155-166.
Title:	Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/beta-catenin signaling.
Author:	Song, Haibin\|Yu, Zhuo\|Sun, Xuehua\|Feng, Jun\|Yu, Qi\|Khan, Hanif\|Zhu, Xiaojun\|Huang, Lingying\|Li, Man\|Mok, Myth T S\|Cheng, Alfred S L\|Gao, Yueqiu\|Feng, Hai
PMID:	30150059

122.
Journal:	EBioMedicine. 2018 Sep 5. pii: S2352-3964(18)30348-7.
Title:	LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
Author:	Cheng, Di\|Deng, Junge\|Zhang, Bin\|He, Xiaoyu\|Meng, Zhe\|Li, Guolin\|Ye, Huilin\|Zheng, Shangyou\|Wei, Lusheng\|Deng, Xiaogeng\|Chen, Rufu\|Zhou, Jiajia
PMID:	30195653

123.
Journal:	Pathol Res Pract. 2018 Aug 8. pii: S0344-0338(18)30139-0.
Title:	MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
Author:	Huang, Bin\|Huang, Manping\|Li, Qin
PMID:	30274685

124.
Journal:	Biochem Biophys Res Commun. 2018 Oct 17. pii: S0006-291X(18)32184-3.
Title:	HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-beta axis.
Author:	Shi, Yang\|Yang, Xiaohua\|Xue, Xiaofeng\|Sun, Ding\|Cai, Peng\|Song, Qingwei\|Zhang, Bin\|Qin, Lei
PMID:	30342849